Caitong International Asset Management’s GeoVax Labs GOVX Stock Holding History

Caitong International Asset Management’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$3	–	3170
2026 Q1	$3	Buy	+2	New	+$5	﹤0.01%	2373
2025 Q3	–	Hold	0	–	-$1	–	2170
2025 Q2	–	Hold	0	–	–	–	1924
2025 Q1	–	Hold	0	–	–	–	2104

Other funds holding GOVX

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return

Caitong International Asset Management's GOVX Position: Q2 2026 in Review

Caitong International Asset Management sold out of GeoVax Labs (GOVX) in Q2 2026, closing a stake of 2 shares — an estimated $3 sold.

Caitong International Asset Management first reported a position in GOVX in Q1 2026 and held it in 1 quarter. The position peaked at $3 in Q1 2026. 11 funds tracked by Wall St. Rank hold GOVX as of Q2 2026.

Caitong International Asset Management reported no remaining GeoVax Labs position as of Q2 2026 after selling out during the quarter.
Caitong International Asset Management sold 2 GeoVax Labs shares in Q2 2026, an estimated $3.
Caitong International Asset Management first reported a position in GeoVax Labs in Q1 2026 and held it in 1 quarter.
Caitong International Asset Management's GeoVax Labs position peaked at $3 in Q1 2026.
11 funds tracked by Wall St. Rank held GeoVax Labs as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.